An2 Therapeutics, Inc. · NASDAQ:ANTX
Eric Easom reported a 7.90% stake in An2 Therapeutics, Inc. (Schedule 13G/A)
Event Dec 31, 2025 · Filed Feb 13, 2026
Eric Easom reported a 7.90% stake in An2 Therapeutics, Inc., 2,232,004 shares, as a passive investor on Dec 31, 2025. Filed Feb 13, 2026 (Schedule 13G/A).
- Stake
- 7.90%
- Shares
- 2,232,004
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Eric Easom | 7.90% | 2,232,004 |
Source
Related
- An2 Therapeutics, Inc.
- Eric Easom
- An2 Therapeutics, Inc. shareholders
- Schedule 13G/A · Eric Easom · Feb 13, 2025
- Form 4 · Aziz Kabeer · Oct 13, 2026
- Form 4 · Martin Patricia A. · Oct 13, 2026
- Form 4 · Marks Gilbert Lynn · Oct 13, 2026
- Form 4 · Trenor Cameron C. III · Sep 16, 2026
- Form 4 · Readnour Robin Shane · Sep 11, 2026